David Scadden, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 200 shares at $41.00 ($8K) on 2025-10-08, disclosed to the SEC on 2025-10-10.
Scheduled sale ($8k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2025-08-29 | $8K | — | Filing → |
| AGIO | SELL | 2025-07-15 | $56K | — | Filing → |
| AGIO | SELL | 2024-12-13 | $9K | — | Filing → |